DICE Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- DICE Therapeutics's estimated annual revenue is currently $17.2M per year.
- DICE Therapeutics's estimated revenue per employee is $155,000
Employee Data
- DICE Therapeutics has 111 Employees.
- DICE Therapeutics grew their employee count by 127% last year.
DICE Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientific Officer | Reveal Email/Phone |
2 | VP, Strategic Finance and Business Development | Reveal Email/Phone |
3 | VP, Process Chemistry, DICE Therapeutics | Reveal Email/Phone |
4 | VP, Drug Development Sciences | Reveal Email/Phone |
5 | SVP, CMC | Reveal Email/Phone |
6 | Director DMPK | Reveal Email/Phone |
7 | Director, Vendor & Operations Managment | Reveal Email/Phone |
8 | Executive Director, Computational Chemistry | Reveal Email/Phone |
9 | Director, Business Operations and Financial Planning and Analysis | Reveal Email/Phone |
10 | Senior Director, Head Clinical Operations | Reveal Email/Phone |
DICE Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is DICE Therapeutics?
At DICE, we are expecting more out of medicine. We design and develop innovative oral medicines against biologically validated targets in immunology for the treatment of chronic autoimmune and inflammatory diseases. Through combining innovative chemistry with well-validated biology, our goal is to make medicines more accessible and unlock the potential of oral medicines.\n\nOur team is led by an exceptional group of scientists, R&D executives and company builders with demonstrated track records of progressing programs from discovery through regulatory approval and commercialization. Together, we’re building a team that has a passion for innovation and extensive experience in small molecule drug discovery and development.
keywords:N/AN/A
Total Funding
111
Number of Employees
$17.2M
Revenue (est)
127%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $21.2M | 112 | 42% | $348M |
#2 | $16.5M | 114 | 27% | N/A |
#3 | $75M | 116 | 6% | N/A |
#4 | $25M | 119 | 4% | N/A |
#5 | $32.4M | 120 | 28% | N/A |